Tingholo, Celsa .
HRN: 01-06-96 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2025
CO-AMOXICLAV 625MG (TAB)
06/21/2025
06/28/2025
PO
625mg
BID
Gingivitis
Checking Initial Appropriateness